
    
      This is a prospective, multi-centers, open-label, single-arm study, and the aim of this trial
      is to evaluate the safety of laparoscopic distal D2 radical gastrectomy for the treatment of
      locally advanced gastric cancer (cT3-4a, N-/+, M0) after neoadjuvant chemotherapy.
    
  